Price trends of reimbursed oncological drugs in Switzerland in 2005–2019: A descriptive analysis

Increasing oncological treatment costs are a major global concern with the risk of entailing two-tiered health care. Among cost determining factors is the price of individual drugs. In recognition of the central role of this factor, we present a comprehensive overview of the development of monthly p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yael Rachamin, Christoph Jakob Ackermann, Oliver Senn, Thomas Grischott
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fb515dedab484f0ea4a3b0ad4f96f6bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares